Loading organizations...
§ Private Profile · Sandy, UT, USA
Healthcare distribution company providing diabetes testing supplies and chronic care management products direct to consumers.
Ingram Medical is a technology-driven healthcare distribution company specializing in diabetes testing supplies and chronic care management products delivered directly to consumers' homes at affordable prices. The organization operates within the direct-to-consumer healthcare distribution sector, focusing on enhancing accessibility and affordability for patients with chronic conditions, with a primary emphasis on diabetes care. Its business model centers on efficient supply chain management, ensuring reliable, convenient delivery of essential medical products to patients nationwide. Specific financial details, such as funding rounds, valuation, revenue figures, employee count, or customer base, are not publicly available, nor is information regarding lead investors, key partners, or notable customers. Ingram Medical was established in 2010. Its business model centers on unknown from available sources. The company appears to operate in the direct-to-consumer healthcare distribution space, but specific revenue sources or funding model are not detailed in search results.
Ingram Medical has raised $30.0M across 1 funding round.
Ingram Medical has raised $30.0M in total across 1 funding round.
Ingram Medical has raised $30.0M across 1 funding round. Most recently, it raised $30.0M Series B in September 2013.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Sep 5, 2013 | $30M Series B | Mercato Partners | Intermountain Ventures, Stepstone Group | Announced |
Ingram Medical has raised $30.0M in total across 1 funding round.
Ingram Medical's investors include Mercato Partners, Intermountain Ventures, StepStone Group.